|
1
|
Haddadin L and Sun X: Stem cells in
cancer: From mechanisms to therapeutic strategies. Cells.
14:5382025. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
El-Tanani M, Rabbani SA, Satyam SM,
Rangraze IR, Wali AF, El-Tanani Y and Aljabali AAA: Deciphering the
role of cancer stem cells: Drivers of tumor evolution, therapeutic
resistance, and precision medicine strategies. Cancers (Basel).
17:3822025. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Takebe N, Miele L, Harris PJ, Jeong W,
Bando H, Kahn M, Yang SX and Ivy SP: Targeting Notch, Hedgehog, and
Wnt pathways in cancer stem cells: Clinical update. Nat Rev Clin
Oncol. 12:445–464. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gonzalez RS, Raza A, Propst R, Adeyi O,
Bateman J, Sopha SC, Shaw J and Auerbach A: Recent advances in
digestive tract tumors: Updates from the 5th edition of the world
health organization 'blue book'. Arch Pathol Lab Med. 145:607–626.
2021. View Article : Google Scholar
|
|
6
|
Li K, Dan Z and Nie YQ: Gastric cancer
stem cells in gastric carcinogenesis, progression, prevention and
treatment. World J Gastroenterol. 20:5420–5426. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ayob AZ and Ramasamy TS: Cancer stem cells
as key drivers of tumour progression. J Biomed Sci. 25:202018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jahangiri L: Cancer stem cell markers and
properties across gastrointestinal cancers. Curr. Tissue
Microenviron. Rep. 4:77–89. 2023. View Article : Google Scholar
|
|
9
|
Sarabia-Sánchez MA, Tinajero-Rodríguez JM,
Ortiz-Sánchez E and Alvarado-Ortiz E: Cancer stem cell markers:
Symphonic masters of chemoresistance and immune evasion. Life Sci.
355:1230152024. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhu Y, He S, Wang Z, Xi H, Lu W and Lin X:
Predictive and clinicopathological importance of HMGB2 in various
carcinomas: A meta and bioinformatic approach. Sci Rep.
15:110032025. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang Y, Meng WJ and Wang ZQ: Cancer stem
cells and the tumor microenvironment in gastric cancer. Front
Oncol. 11:8039742022. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang H, Steed A, Co M and Chen X: Cancer
stem cells, epithelial-mesenchymal transition, ATP and their roles
in drug resistance in cancer. Cancer Drug Resist. 4:684–709.
2021.PubMed/NCBI
|
|
13
|
Sinha S, Hembram KC and Chatterjee S:
Targeting signaling pathways in cancer stem cells: A potential
approach for developing novel anti-cancer therapeutics. Int Rev
Cell Mol Biol. 385:157–209. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Becerril-Rico J, Alvarado-Ortiz E,
Toledo-Guzmán ME, Pelayo R and Ortiz-Sánchez E: The cross talk
between gastric cancer stem cells and the immune microenvironment:
a tumor-promoting factor. Stem Cell Res Ther. 12:4982021.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kapoor-Narula U and Lenka N: Cancer stem
cells and tumor heterogeneity: Deciphering the role in tumor
progression and metastasis. Cytokine. 157:1559682022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Otaegi-Ugartemendia M, Matheu A and
Carrasco-Garcia E: Impact of cancer stem cells on therapy
resistance in gastric cancer. Cancers (Basel). 14:14572022.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang C, Xie J, Guo J, Manning HC, Gore JC
and Guo N: Evaluation of CD44 and CD133 as cancer stem cell markers
for colorectal cancer. Oncol Rep. 28:1301–1308. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dhumal SN, Choudhari SK, Patankar S, Ghule
SS, Jadhav YB and Masne S: Cancer stem cell markers, CD44 and
ALDH1, for assessment of cancer risk in OPMDs and lymph node
metastasis in oral squamous cell carcinoma. Head Neck Pathol.
16:453–465. 2022. View Article : Google Scholar :
|
|
19
|
Hassn Mesrati M, Syafruddin SE, Mohtar MA
and Syahir A: CD44: A multifunctional mediator of cancer
progression. Biomolecules. 11:18502021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gopalan V Islam F and Lam AK: Surface
markers for the identification of cancer stem cells. Methods Mol
Biol. 1692:17–29. 2018. View Article : Google Scholar
|
|
21
|
Makohon-Moore A and Iacobuzio-Donahue CA:
Pancreatic cancer biology and genetics from an evolutionary
perspective. Nat Rev Cancer. 16:553–565. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tian S, Ma R, Liu Y, Chen F, Huang X, Yang
Q, Nian W and Fan Z: Clinicopathological significance of cancer
stem cell marker CD44/SOX2 in esophageal squamous cell carcinoma
(ESCC) patients and construction of a nomogram to predict overall
survival. Transl Cancer Res. 13:2971–2984. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang G, Yuan C, Zhang C, Yang F, Tan Y,
Chen D, Li H and Qian K: Single-cell sequencing reveals the immune
microenvironment associated with gastric cancer. Genes Dis.
12:1012182025. View Article : Google Scholar
|
|
24
|
Xue C, Chu Q, Shi Q, Zeng Y, Lu J and Li
L: Wnt signaling pathways in biology and disease: Mechanisms and
therapeutic advances. Signal Transduct Target Ther. 10:1062025.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shang T, Jia Z, Li J, Cao H, Xu H, Cong L,
Ma D, Wang X and Liu J: Unraveling the triad of hypoxia, cancer
cell stemness, and drug resistance. J Hematol Oncol. 18:322025.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang S, Wang Y, Xun X, Zhang C, Xiang X,
Cheng Q, Hu S, Li Z and Zhu J: Hedgehog signaling promotes
sorafenib resistance in hepatocellular carcinoma patient-derived
organoids. J Exp Clin Cancer Res. 39:222020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tufail M, Jiang CH and Li N: Wnt signaling
in cancer: From biomarkers to targeted therapies and clinical
translation. Mol Cancer. 24:1072025. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lanauze CB, Sehgal P, Hayer K, Torres-Diz
M, Pippin JA, Grant SFA and Thomas-Tikhonenko A: Colorectal
Cancer-Associated Smad4 R361 Hotspot Mutations Boost Wnt/β-Catenin
Signaling through Enhanced Smad4-LEF1 Binding. Mol Cancer Res.
19:823–833. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
López-Knowles E, Zardawi SJ, McNeil CM,
Millar EK, Crea P, Musgrove EA, Sutherland RL and O'Toole SA:
Cytoplasmic localization of beta-catenin is a marker of poor
outcome in breast cancer patients. Cancer Epidemiol Biomarkers
Prev. 19:301–309. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Aine M, Nacer DF, Arbajian E, Veerla S,
Karlsson A, Häkkinen J, Johansson HJ, Rosengren F,
Vallon-Christersson J, Borg A and Staaf J: The DNA methylation
landscape of primary triple-negative breast cancer. Nat Commun.
16:30412025. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang Z and Zhang Y: Transcriptional
regulation of cancer stem cell: regulatory factors elucidation and
cancer treatment strategies. J Exp Clin Cancer Res. 43:992024.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Darwiche N: Epigenetic mechanisms and the
hallmarks of cancer: An intimate affair. Am J Cancer Res.
10:1954–1978. 2020.PubMed/NCBI
|
|
33
|
Liu B, Peng Z, Zhang H, Zhang N, Liu Z,
Xia Z, Huang S, Luo P and Cheng Q: Regulation of cellular
senescence in tumor progression and therapeutic targeting:
mechanisms and pathways. Mol Cancer. 24:1062025. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Quail DF and Joyce JA: Microenvironmental
regulation of tumor progression and metastasis. Nat Med.
19:1423–1437. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jia H, Chen X, Zhang L and Chen M: Cancer
associated fibroblasts in cancer development and therapy. J Hematol
Oncol. 18:362025. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shi Z, Hu C, Li Q and Sun C:
Cancer-associated fibroblasts as the 'Architect' of the lung cancer
immune microenvironment: Multidimensional roles and synergistic
regulation with radiotherapy. Int J Mol Sci. 26:32342025.
View Article : Google Scholar
|
|
37
|
Yu S, Wang S, Wang X and Xu X: The axis of
tumor-associated macrophages, extracellular matrix proteins, and
cancer-associated fibroblasts in oncogenesis. Cancer Cell Int.
24:3352024. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Huang B, Lang X and Li X: The role of
IL-6/JAK2/STAT3 signaling pathway in cancers. Front Oncol.
12:10231772022. View Article : Google Scholar :
|
|
39
|
Li YR, Fang Y, Lyu Z, Zhu Y and Yang L:
Exploring the dynamic interplay between cancer stem cells and the
tumor microenvironment: Implications for novel therapeutic
strategies. J Transl Med. 21:6862023. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Rabinovich I, Sebastião APM, Lima RS,
Urban CA, Junior ES, Anselmi KF, Elifio-Esposito S, De Noronha L
and Moreno-Amaral AN: Cancer stem cell markers ALDH1 and
CD44+/CD24− phenotype and their prognosis impact in invasive ductal
carcinoma. Eur J Histochem. 62:29432018.
|
|
41
|
Wang D, Li Y, Ge H, Ghadban T, Reeh M and
Güngör C: The extracellular matrix: A key accomplice of cancer stem
cell migration, metastasis formation, and drug resistance in PDAC.
Cancers (Basel). 14:39982022. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tie Y, Tang F, Wei YQ and Wei XW:
Immunosuppressive cells in cancer: Mechanisms and potential
therapeutic targets. J Hematol Oncol. 15:612022. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yin B, Cai Y, Chen L, Li Z and Li X:
Immunosuppressive MDSC and Treg signatures predict prognosis and
therapeutic response in glioma. Int Immunopharmacol.
141:1129222024. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lin Y, Song Y, Zhang Y, Li X, Kan L and
Han S: New insights on anti-tumor immunity of CD8+ T cells: Cancer
stem cells, tumor immune microenvironment and immunotherapy. J
Transl Med. 23:3412025. View Article : Google Scholar :
|
|
45
|
Galassi C, Musella M, Manduca N, Maccafeo
E and Sistigu A: The immune privilege of cancer stem cells: A key
to understanding tumor immune escape and therapy failure. Cells.
10:23612021. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Luo H, Hu B, Gu XR, Chen J, Fan XQ, Zhang
W, Wang RT, He XD, Guo W, Dai N, et al: The miR-23a/27a/24 − 2
cluster drives immune evasion and resistance to PD-1/PD-L1 blockade
in non-small cell lung cancer. Mol Cancer. 23:2852024. View Article : Google Scholar
|
|
47
|
Geng S, Zhu L, Wang Y, Liu Q, Yu C, Shi S
and Yu S: Co-Colorectal cancer stem cells employ the FADS1/DDA axis
to evade NK cell-mediated immunosuppression after co-cultured with
NK cells under hypoxia. Int Immunopharmacol. 143(Pt 3): 1135352024.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Liu S, Zhao H, Hu Y, Yan C, Mi Y, Li X,
Tao D and Qin J: Lactate promotes metastasis of normoxic colorectal
cancer stem cells through PGC-1α-mediated oxidative
phosphorylation. Cell Death Dis. 13:6512022. View Article : Google Scholar
|
|
49
|
Guo S, Zhao W, Zhang W, Li S, Teng G and
Liu L: Vitamin D promotes ferroptosis in colorectal cancer stem
cells via SLC7A11 downregulation. Oxid Med Cell Longev.
2023:47721342023. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhang Q, Tian H, Ge K and Wang F, Gao P,
Chen A, Wang L, Zhao Y, Lian C and Wang F: PGD2/PTGDR2 signaling
pathway affects the self-renewal capacity of gastric cancer stem
cells by regulating ATG4B ubiquitination. Front Oncol.
14:14960502024. View Article : Google Scholar
|
|
51
|
Chen Y, Li D, Wang D, Liu X, Yin N, Song
Y, Lu SH, Ju Z and Zhan Q: Quiescence and attenuated DNA damage
response promote survival of esophageal cancer stem cells. J Cell
Biochem. 113:3643–3652. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zhao Y, Bao Q, Schwarz B, Zhao L,
Mysliwietz J, Ellwart J, Renner A, Hirner H, Niess H, Camaj P, et
al: Stem cell-like side populations in esophageal cancer: A source
of chemotherapy resistance and metastases. Stem Cells Dev.
23:180–192. 2014. View Article : Google Scholar
|
|
53
|
Song S, Ajani JA, Honjo S, Maru DM, Chen
Q, Scott AW, Heallen TR, Xiao L, Hofstetter WL, Weston B, et al:
Hippo coactivator YAP1 upregulates SOX9 and endows esophageal
cancer cells with stem-like properties. Cancer Res. 74:4170–4182.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Xu DD, Zhou PJ, Wang Y, Zhang L, Fu WY,
Ruan BB, Xu HP, Hu CZ, Tian L, Qin JH, et al: Reciprocal activation
between STAT3 and miR-181b regulates the proliferation of
esophageal cancer stem-like cells via the CYLD pathway. Mol Cancer.
15:402016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Liu CC, Chou KT, Hsu JW, Lin JH, Hsu TW,
Yen DH, Hung SC and Hsu HS: High metabolic rate and stem cell
characteristics of esophageal cancer stem-like cells depend on the
Hsp27-AKT-HK2 pathway. Int J Cancer. 145:2144–2156. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Kai JD, Cheng LH, Li BF, Kang K, Xiong F,
Fu JC and Wang S: MYH9 is a novel cancer stem cell marker and
prognostic indicator in esophageal cancer that promotes oncogenesis
through the PI3K/AKT/mTOR axis. Cell Biol Int. 46:2085–2094. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Wang X, Cao Y, Zhang S, Chen Z, Fan L,
Shen X, Zhou S and Chen D: Stem cell autocrine CXCL12/CXCR4
stimulates invasion and metastasis of esophageal cancer.
Oncotarget. 8:36149–36160. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Yue D, Zhang Z, Li J, Chen X, Ping Y, Liu
S, Shi X, Li L, Wang L, Huang L, et al: Transforming growth
factor-beta1 promotes the migration and invasion of sphere-forming
stem-like cell subpopulations in esophageal cancer. Exp Cell Res.
336:141–149. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Wei JR, Zhang B, Zhang Y, Chen WM, Zhang
XP, Zeng TT, Li Y, Zhu YH, Guan XY and Li L: QSOX1 facilitates
dormant esophageal cancer stem cells to evade immune elimination
via PD-L1 upregulation and CD8 T cell exclusion. Proc Natl Acad Sci
USA. 121:e24075061212024. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Guo M, Lian J, Liu Y, Dong B, He Q, Zhao
Q, Zhang H, Qi Y, Zhang Y and Huang L: Loss of miR-637 promotes
cancer cell stemness via WASH/IL-8 pathway and serves as a novel
prognostic marker in esophageal squamous cell carcinoma. Biomark
Res. 10:772022. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Xun J, Ma Y, Wang B, Jiang X, Liu B, Gao
R, Zhai Q, Cheng R, Wu X, Wu Y and Zhang Q: RGS1 targeted by
miR-191-3p inhibited the stemness properties of esophageal cancer
cells by suppressing CXCR4/PI3K/AKT signaling. Acta Histochem.
126:1521902024. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Yu X, Teng Y, Jiang X, Yuan H and Jiang W:
Genome-Wide DNA methylation pattern of cancer stem cells in
esophageal cancer. Technol Cancer Res Treat.
19:15330338209837932020. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Gupta P, Rizvi SZ, Lal N, Gupta V,
Srivastav AN and Musa O: Expression of CD44 and CD133 stem cell
markers in squamous cell carcinoma of esophagus. Indian J Pathol
Microbiol. 64:472–478. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Xu DD, Chen SH, Zhou PJ, Wang Y, Zhao ZD,
Wang X, Huang HQ, Xue X, Liu QY, Wang YF and Zhang R: Suppression
of Esophageal Cancer Stem-like Cells by SNX-2112 Is Enhanced by
STAT3 Silencing. Front Pharmacol. 11:5323952020. View Article : Google Scholar :
|
|
65
|
Liu CC, Li HH, Lin JH, Chiang MC, Hsu TW,
Li AF, Yen DH, Hsu HS and Hung SC: Esophageal Cancer Stem-like
Cells Resist Ferroptosis-Induced Cell Death by Active Hsp27-GPX4
Pathway. Biomolecules. 12:482021. View Article : Google Scholar
|
|
66
|
Mao J, Fan S, Ma W, Fan P, Wang B, Zhang
J, Wang H, Tang B, Zhang Q, Yu X, et al: Roles of Wnt/β-catenin
signaling in the gastric cancer stem cells proliferation and
salinomycin treatment. Cell Death Dis. 5:e10392014. View Article : Google Scholar
|
|
67
|
Xu XF, Gao F, Wang JJ, Long C, Chen X, Tao
L, Yang L, Ding L and Ji Y: BMX-ARHGAP fusion protein maintains the
tumorigenicity of gastric cancer stem cells by activating the
JAK/STAT3 signaling pathway. Cancer Cell Int. 19:1332019.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Wu Q, Yang Z, Wang F, Hu S, Yang L, Shi Y
and Fan D: MiR-19b/20a/92a regulates the self-renewal and
proliferation of gastric cancer stem cells. J Cell Sci. 126(Pt 18):
4220–4229. 2013.PubMed/NCBI
|
|
69
|
Han ME, Baek SJ, Kim SY, Kang CD and Oh
SO: ATOH1 can regulate the tumorigenicity of gastric cancer cells
by inducing the differentiation of cancer stem cells. PLoS One.
10:e01260852015. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Shen C, Wang J, Xu Z, Zhang L, Gu W and
Zhou X: ONECUT2 which is targeted by hsa-miR-15a-5p enhances
stemness maintenance of gastric cancer stem cells. Exp Biol Med
(Maywood). 246:2645–2659. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Li LQ, Pan D, Zhang SWY, Xie D, Zheng XL
and Chen H: Autophagy regulates chemoresistance of gastric cancer
stem cells via the Notch signaling pathway. Eur Rev Med Pharmacol
Sci. 22:3402–3407. 2018.PubMed/NCBI
|
|
72
|
Xin L, Li SH, Liu C, Zeng F, Cao JQ, Zhou
LQ, Zhou Q and Yuan YW: Methionine represses the autophagy of
gastric cancer stem cells via promoting the methylation and
phosphorylation of RAB37. Cell Cycle. 19:2644–2652. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Togano S, Yashiro M, Masuda G, Sugimoto A,
Miki Y, Yamamoto Y, Sera T, Kushiyama S, Nishimura S, Kuroda K, et
al: Gastric cancer stem cells survive in stress environments via
their autophagy system. Sci Rep. 11:206642021. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Yang SW, Zhang ZG, Hao YX, Zhao YL, Qian
F, Shi Y, Li PA, Liu CY and Yu PW: HIF-1α induces the
epithelial-mesenchymal transition in gastric cancer stem cells
through the Snail pathway. Oncotarget. 8:9535–9545. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Sun LF, Yang K, Wang YG, Liu YX, Hou PX,
Lu ZH, Chen XL, Zhang WH, Zhou ZG, Mo XM and Hu JK: The Role of
HER2 in self-renewal, invasion, and tumorigenicity of gastric
cancer stem cells. Front Oncol. 10:16082020. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Seeneevassen L, Giraud J, Molina-Castro S,
Sifré E, Tiffon C, Beauvoit C, Staedel C, Mégraud F, Lehours P,
Martin OCB, et al: Leukaemia inhibitory factor (LIF) inhibits
cancer stem cells tumorigenic properties through hippo kinases
activation in gastric cancer. Cancers (Basel). 12:20112020.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Zhang Q and Wang F, Huang Y, Gao P, Wang
N, Tian H, Chen A, Li Y and Wang F: PGD2/PTGDR2 signal affects the
viability, invasion, apoptosis, and stemness of gastric cancer stem
cells and prevents the progression of gastric cancer. Comb Chem
High Throughput Screen. 27:933–946. 2024. View Article : Google Scholar
|
|
78
|
Wang X, Zhang F, Yang J, Huang X, Chao X,
Ayidu A and Abudureyimu A: The chemotherapeutic effect of
docetaxel, cisplatin and fluorouracil regimen on gastric cancer
stem cells. J Nanosci Nanotechnol. 17:983–999. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Zhang H, Wang M, He Y, Deng T, Liu R, Wang
W, Zhu K, Bai M, Ning T, Yang H, et al: Chemotoxicity-induced
exosomal lncFERO regulates ferroptosis and stemness in gastric
cancer stem cells. Cell Death Dis. 12:11162021. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Mao X, Wang L, Chen Z, Huang H, Chen J, Su
J, Li Z, Shen G, Ren Y, Li Z, et al: SCD1 promotes the stemness of
gastric cancer stem cells by inhibiting ferroptosis through the
SQLE/cholesterol/mTOR signalling pathway. Int J Biol Macromol.
275(Pt 2): 1336982024. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Ni T, Chu Z, Tao L, Zhao Y, Lv M, Zhu M,
Luo Y, Sunagawa M, Wang H and Liu Y: Celastrus orbiculatus extract
suppresses gastric cancer stem cells through the TGF-β/Smad
signaling pathway. J Nat Med. 78:100–113. 2024. View Article : Google Scholar
|
|
82
|
Chen B, Zhang D, Kuai J, Cheng M, Fang X
and Li G: Upregulation of miR-199a/b contributes to cisplatin
resistance via Wnt/β-catenin-ABCG2 signaling pathway in ALDHA1(+)
colorectal cancer stem cells. Tumour Biol. 39:10104283177151552017.
View Article : Google Scholar
|
|
83
|
Li J, Yu B, Deng P, Cheng Y, Yu Y, Kevork
K, Ramadoss S, Ding X, Li X and Wang CY: KDM3 epigenetically
controls tumorigenic potentials of human colorectal cancer stem
cells through Wnt/β-catenin signalling. Nat Commun. 8:151462017.
View Article : Google Scholar
|
|
84
|
Hua F, Shang S, Yang YM, Zhang HZ, Xu TL,
Yu JJ, Zhou DD, Cui B, Li K, Lv XX, et al: TRIB3 interacts With
β-Catenin and TCF4 to increase stem cell features of colorectal
cancer stem cells and tumorigenesis. Gastroenterology.
156:708–721.e15. 2019. View Article : Google Scholar
|
|
85
|
Yu W, Ma Y, Shankar S and Srivastava RK:
SATB2/β-catenin/TCF-LEF pathway induces cellular transformation by
generating cancer stem cells in colorectal cancer. Sci Rep.
7:109392017. View Article : Google Scholar
|
|
86
|
Zhu Y, Huang S, Chen S, Chen J, Wang Z,
Wang Y and Zheng H: SOX2 promotes chemoresistance, cancer stem
cells properties, and epithelial-mesenchymal transition by
β-catenin and Beclin1/autophagy signaling in colorectal cancer.
Cell Death Dis. 12:4492021. View Article : Google Scholar
|
|
87
|
Izumi D, Ishimoto T, Miyake K, Eto T,
Arima K, Kiyozumi Y, Uchihara T, Kurashige J, Iwatsuki M, Baba Y,
et al: Colorectal cancer stem cells acquire chemoresistance through
the upregulation of F-Box/WD repeat-containing protein 7 and the
consequent degradation of c-Myc. Stem Cells. 35:2027–2036. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Honma S, Hisamori S, Nishiuchi A, Itatani
Y, Obama K, Shimono Y and Sakai Y: F-Box/WD repeat
domain-containing 7 induces chemotherapy resistance in colorectal
cancer stem cells. Cancers (Basel). 11:6352019. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Mukohyama J, Isobe T, Hu Q, Hayashi T,
Watanabe T, Maeda M, Yanagi H, Qian X, Yamashita K, Minami H, et
al: miR-221 Targets QKI to Enhance the tumorigenic capacity of
human colorectal cancer stem cells. Cancer Res. 79:5151–5158. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Liu L, Zhang Z, Zhou L, Hu L, Yin C, Qing
D, Huang S, Cai X and Chen Y: Cancer associated fibroblasts-derived
exosomes contribute to radioresistance through promoting colorectal
cancer stem cells phenotype. Exp Cell Res. 391:1119562020.
View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Montalbán-Hernández K, Cantero-Cid R,
Casalvilla-Dueñas JC, Avendaño-Ortiz J, Marín E, Lozano-Rodríguez
R, Ter rón-A rcos V, Vica r io-Bravo M, Ma rcano C,
Saavedra-Ambrosy J, et al: Colorectal cancer stem cells fuse with
monocytes to form tumour hybrid cells with the ability to migrate
and evade the immune system. Cancers (Basel). 14:34452022.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Cavallucci V, Palucci I, Fidaleo M,
Mercuri A, Masi L, Emoli V, Bianchetti G, Fiori ME, Bachrach G,
Scaldaferri F, et al: Proinflammatory and cancer-promoting
pathobiont fusobacterium nucleatum directly targets colorectal
cancer stem cells. Biomolecules. 12:12562022. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Tamura S, Isobe T, Ariyama H, Nakano M,
Kikushige Y, Takaishi S, Kusaba H, Takenaka K, Ueki T, Nakamura M,
et al: E-cadherin regulates proliferation of colorectal cancer stem
cells through NANOG. Oncol Rep. 40:693–703. 2018.PubMed/NCBI
|
|
94
|
Zou W, Zhang Y, Bai G, Zhuang J, Wei L,
Wang Z, Sun M and Wang J: siRNA-induced CD44 knockdown suppresses
the proliferation and invasion of colorectal cancer stem cells
through inhibiting epithelial-mesenchymal transition. J Cell Mol
Med. 26:1969–1978. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Vishnubalaji R, Manikandan M, Fahad M,
Hamam R, Alfayez M, Kassem M, Aldahmash A and Alajez NM: Molecular
profiling of ALDH1(+) colorectal cancer stem cells reveals
preferential activation of MAPK, FAK, and oxidative stress
pro-survival signalling pathways. Oncotarget. 9:13551–13564. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Agawa K, Yamashita K, Nakagawa A, Yamada
K, Watanabe A, Mukohyama J, Saito M, Fujita M, Takiguchi G, Urakawa
N, et al: Simple cancer stem cell markers predict neoadjuvant
chemotherapy resistance of esophageal squamous cell carcinoma.
Anticancer Res. 41:4117–4126. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Lin CH, Li HY, Liu YP, Kuo PF, Wang WC,
Lin FC, Chang WL, Sheu BS, Wang YC, Hung WC, et al: High-CLDN4 ESCC
cells harbor stem-like properties and indicate for poor concurrent
chemoradiation therapy response in esophageal squamous cell
carcinoma. Ther Adv Med Oncol. 11:17588359198753242019. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Trevellin E, Pirozzolo G, Fassan M and
Vettor R: Prognostic value of stem cell markers in esophageal and
esophagogastric junction cancer: A meta-analysis. J Cancer.
11:4240–4249. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Nishikawa S, Konno M, Hamabe A, Hasegawa
S, Kano Y, Ohta K, Fukusumi T, Sakai D, Kudo T, Haraguchi N, et al:
Aldehyde dehydrogenase high gastric cancer stem cells are resistant
to chemotherapy. Int J Oncol. 42:1437–1442. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Gong DY, Chen X, Yang TL, Wang Y, Guo Y,
Zeng JH and Chen SZ: Upregulation of ECT2 is associated with
transcriptional program of cancer stem cells and predicts poor
clinical outcome in gastric cancer. Oncol Lett.
20:542020.PubMed/NCBI
|
|
101
|
Becerril-Rico J, Grandvallet-Contreras J,
Ruíz-León MP, Dorantes-Cano S, Ramírez-Vidal L, Tinajero-Rodríguez
JM and Ortiz-Sánchez E: Circulating gastric cancer stem cells as
blood screening and prognosis factor in gastric cancer. Stem Cells
Int. 2024:99991552024. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Catalano V, Dentice M, Ambrosio R, Luongo
C, Carollo R, Benfante A, Todaro M, Stassi G and Salvatore D:
Activated thyroid hormone promotes differentiation and
chemotherapeutic sensitization of colorectal cancer stem cells by
regulating Wnt and BMP4 signaling. Cancer Res. 76:1237–1244. 2016.
View Article : Google Scholar
|
|
103
|
Prieur A, Cappellini M, Habif G, Lefranc
MP, Mazard T, Morency E, Pascussi JM, Flacelière M, Cahuzac N, Vire
B, et al: Targeting the Wnt pathway and cancer stem cells with
anti-progastrin humanized antibodies as a potential treatment for
K-RAS-mutated colorectal cancer. Clin Cancer Res. 23:5267–5280.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Chen Q, Song S, Wei S, Liu B, Honjo S,
Scott A, Jin J, Ma L, Zhu H, Skinner HD, et al: ABT-263 induces
apoptosis and synergizes with chemotherapy by targeting stemness
pathways in esophageal cancer. Oncotarget. 6:25883–25896. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Narusaka T, Ohara T, Noma K, Nishiwaki N,
Katsura Y, Kato T, Sato H, Tomono Y, Kikuchi S, Tazawa H, et al:
Nanog is a promising chemoresistant stemness marker and therapeutic
target by iron chelators for esophageal cancer. Int J Cancer.
149:347–357. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Xu ZY, Tang JN, Xie HX, Du YA, Huang L, Yu
PF and Cheng XD: 5-Fluorouracil chemotherapy of gastric cancer
generates residual cells with properties of cancer stem cells. Int
J Biol Sci. 11:284–294. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Liu C, Wang JL, Wu DZ, Yuan YW and Xin L:
Methionine restriction enhances the chemotherapeutic sensitivity of
colorectal cancer stem cells by miR-320d/c-Myc axis. Mol Cell
Biochem. 477:2001–2013. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Yu M, Fei B and Chu S: Targeting HNRNPA2B1
to overcome chemotherapy resistance in gastric cancer stem cells:
Mechanisms and therapeutic potential. J Biol Chem. 301:1082342025.
View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Kim MJ, Koo JE, Han GY, Kim B, Lee YS, Ahn
C and Kim CW: Dual-Blocking of PI3K and mTOR improves
chemotherapeutic effects on SW620 human colorectal cancer stem
cells by inducing differentiation. J Korean Med Sci. 31:360–370.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Tsunekuni K, Konno M, Haraguchi N, Koseki
J, Asai A, Matsuoka K, Kobunai T, Takechi T, Doki Y, Mori M and
Ishii H: CD44/CD133-positive colorectal cancer stem cells are
sensitive to trifluridine exposure. Sci Rep. 9:148612019.
View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Khoei SG, Sadeghi H and Dermani FK:
Targeting the SPHK1/HIF1 PATHWAY TO INHIBIT colorectal cancer stem
cells niche. J Gastrointest Cancer. 51:716–717. 2020. View Article : Google Scholar
|
|
112
|
Rio-Vilariño A, Cenigaonandia-Campillo A,
García-Bautista A, Mateos-Gómez PA, Schlaepfer MI, Del
Puerto-Nevado L, Aguilera O, García-García L, Galeano C, de Miguel
I, et al: Inhibition of the AURKA/YAP1 axis is a promising
therapeutic option for overcoming cetuximab resistance in
colorectal cancer stem cells. Br J Cancer. 130:1402–1413. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Akrami H, Moradi B, Borzabadi Farahani D
and Mehdizadeh K: Ibuprofen reduces cell proliferation through
inhibiting Wnt/β catenin signaling pathway in gastric cancer stem
cells. Cell Biol Int. 42:949–958. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Chen Y, Li Y, Wang XQ, Meng Y, Zhang Q,
Zhu JY, Chen JQ, Cao WS, Wang XQ, Xie CF, et al: Phenethyl
isothiocyanate inhibits colorectal cancer stem cells by suppressing
Wnt/β-catenin pathway. Phytother Res. 32:2447–2455. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Chen Y, Wang XQ, Zhang Q, Zhu JY, Li Y,
Xie CF, Li XT, Wu JS, Geng SS, Zhong CY and Han HY:
(-)-epigallocatechin-3-gallate inhibits colorectal cancer stem
cells by suppressing Wnt/β-catenin pathway. Nutrients. 9:5722017.
View Article : Google Scholar
|
|
116
|
Qi J, Cui D, Wu QN, Zhao Q, Chen ZH, Li L,
Birchmeier W, Yu Y and Tao R: Targeting Wnt/β-catenin signaling by
TET1/FOXO4 inhibits metastatic spreading and self-renewal of cancer
stem cells in gastric cancer. Cancers (Basel). 14:32322022.
View Article : Google Scholar
|
|
117
|
Wen Z, Feng S, Wei L, Wang Z, Hong D and
Wang Q: Evodiamine, a novel inhibitor of the Wnt pathway, inhibits
the self-renewal of gastric cancer stem cells. Int J Mol Med.
36:1657–1663. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Sun J, Zhang S and Wang M, Cheng H, Wang
Y, He S, Zuo Q, Wang N, Li Q and Wang M: Cinobufacini enhances the
therapeutic response of 5-Fluorouracil against gastric cancer by
targeting cancer stem cells via AKT/GSK-3β/β-catenin signaling
axis. Transl Oncol. 47:1020542024. View Article : Google Scholar
|
|
119
|
Cao W, Li Y, Sun H, Yang C, Zhu J, Xie C,
Li X, Wu J, Geng S, Wang L, et al: Apatinib suppresses gastric
cancer stem cells properties by inhibiting the sonic hedgehog
pathway. Front Cell Dev Biol. 9:6798062021. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Yang C, Zheng X, Ye K, Sun Y, Lu Y, Fan Q
and Ge H: miR-135a inhibits the invasion and migration of
esophageal cancer stem cells through the hedgehog signaling pathway
by targeting Smo. Mol Ther Nucleic Acids. 19:841–852. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Giraud J, Molina-Castro S, Seeneevassen L,
Sifré E, Izotte J, Tiffon C, Staedel C, Boeuf H, Fernandez S,
Barthelemy P, et al: Verteporfin targeting YAP1/TAZ-TEAD
transcriptional activity inhibits the tumorigenic properties of
gastric cancer stem cells. Int J Cancer. 146:2255–2267. 2020.
View Article : Google Scholar
|
|
122
|
Jang MK, Mashima T and Seimiya H:
Tankyrase inhibitors target colorectal cancer stem cells via
AXIN-dependent downregulation of c-KIT tyrosine kinase. Mol Cancer
Ther. 19:765–776. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Hu CT, Lin CF, Shih HM, You RI, Wu WS and
Chen TC: Blockade of Src signaling prevented stemness gene
expression and proliferation of patient-derived gastric cancer stem
cells. Tzu Chi Med J. 37:65–71. 2024. View Article : Google Scholar
|
|
124
|
Lamichhane A, Shahi Thakuri P, Singh S,
Rafsanjani Nejad P, Heiss J, Luker GD and Tavana H: Therapeutic
targeting of cancer stem cells prevents resistance of colorectal
cancer cells to MEK inhibition. ACS Pharmacol Transl Sci.
5:724–734. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Song S, Chen Q, Li Y, Lei G, Scott A, Huo
L, Li CY, Estrella JS, Correa A, Pizzi MP, et al: Targeting cancer
stem cells with a pan-BCL-2 inhibitor in preclinical and clinical
settings in patients with gastroesophageal carcinoma. Gut.
70:2238–2248. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Park SR, Kim SR, Hong IS and Lee HY: A
novel therapeutic approach for colorectal cancer stem cells:
Blocking the PI3K/Akt signaling axis with caffeic acid. Front Cell
Dev Biol. 8:5859872020. View Article : Google Scholar
|
|
127
|
Yao HJ, Zhang YG, Sun L and Liu Y: The
effect of hyaluronic acid functionalized carbon nanotubes loaded
with salinomycin on gastric cancer stem cells. Biomaterials.
35:9208–9223. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Andrade F, Rafael D, Vilar-Hernández M,
Montero S, Martínez-Trucharte F, Seras-Franzoso J, Díaz-Riascos ZV,
Boullosa A, García-Aranda N, Cámara-Sánchez P, et al: Polymeric
micelles targeted against CD44v6 receptor increase niclosamide
efficacy against colorectal cancer stem cells and reduce
circulating tumor cells in vivo. J Control Release. 331:198–212.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Quarni W, Dutta R, Green R, Katiri S,
Patel B, Mohapatra SS and Mohapatra S: Mithramycin a inhibits
colorectal cancer growth by targeting cancer stem cells. Sci Rep.
9:152022019. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
AlShamaileh H, Wang T, Xiang D, Yin W,
Tran PH, Barrero RA, Zhang PZ, Li Y, Kong L, Liu K, et al:
Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate
colorectal cancer stem cells. Sci Rep. 7:58982017. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Zhu L and Wang H: Cholesterol-regulated
cellular stiffness may enhance evasion of NK cell-mediated
cytotoxicity in gastric cancer stem cells. FEBS Open Bio.
14:855–866. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Chen W, Dong J, Haiech J, Kilhoffer MC and
Zeniou M: Cancer stem cell quiescence and plasticity as major
challenges in cancer therapy. Stem Cells Int. 2016:17409362016.
View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Huang T, Song X, Xu D, Tiek D, Goenka A,
Wu B, Sastry N, Hu B and Cheng SY: Stem cell programs in cancer
initiation, progression, and therapy resistance. Theranostics.
10:8721–8743. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Kim R, Ji JH, Kim JH, Hong JY, Lim HY,
Kang WK, Lee J and Kim ST: Safety and anti-tumor effects of
vismodegib in patients with refractory advanced gastric cancer: A
single-arm, phase-II trial. J Cancer. 13:1097–1102. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Rao X, Zhang C, Luo H, Zhang J, Zhuang Z,
Liang Z and Wu X: Targeting gastric cancer stem cells to enhance
treatment response. Cells. 11:28282022. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Zhong B, Cheng B, Huang X, Xiao Q, Niu Z,
Chen YF, Yu Q, Wang W and Wu XJ: Colorectal cancer-associated
fibroblasts promote metastasis by up-regulating LRG1 through
stromal IL-6/STAT3 signaling. Cell Death Dis. 13:162021. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Luo J, Chen H, Ma F, Xiao C, Sun B, Liu Y,
Tang H, Yang Y, Liu W and Luo Z: Vitamin D metabolism pathway
polymorphisms are associated with efficacy and safety in patients
under anti-PD-1 inhibitor therapy. Front Immunol. 13:9374762022.
View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Krishnamurthy N and Kurzrock R: Targeting
the Wnt/beta-catenin pathway in cancer: Update on effectors and
inhibitors. Cancer Treat Rev. 62:50–60. 2018. View Article : Google Scholar
|
|
139
|
Mohan A, Raj Rajan R, Mohan G, Kollenchery
Puthenveettil P and Maliekal TT: Markers and reporters to reveal
the hierarchy in heterogeneous cancer stem cells. Front Cell Dev
Biol. 9:6688512021. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Li Y, Lu Y, Wu M, Wang H, Gong Y and Gu Y:
Neogambogic acid suppresses characteristics and growth of
colorectal cancer stem cells by inhibition of DLK1 and
Wnt/β-catenin pathway. Eur J Pharmacol. 929:1751122022. View Article : Google Scholar
|
|
141
|
Zaafour A, Seeneevassen L, Nguyen TL,
Genevois C, Nicolas N, Sifré E, Giese A, Porcheron C, Descarpentrie
J, Dubus P, et al: Inhibition of proprotein convertases activity
results in repressed stemness and invasiveness of cancer stem cells
in gastric cancer. Gastric Cancer. 27:292–307. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Santos LS, Silva VR, de Castro MVL, Dias
RB, Valverde LF, Rocha CAG, Soares MBP, Quadros CA, Dos Santos ER,
Oliveira RMM, et al: New ruthenium-xanthoxylin complex eliminates
colorectal cancer stem cells by targeting the heat shock protein 90
chaperone. Cell Death Dis. 14:8322023. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Soufizadeh P, Mansouri V and Ahmadbeigi N:
A review of animal models utilized in preclinical studies of
approved gene therapy products: trends and insights. Lab Anim Res.
40:172024. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Johnson JI, Decker S, Zaharevitz D,
Rubinstein LV, Venditti JM, Schepartz S, Kalyandrug S, Christian M,
Arbuck S, Hollingshead M and Sausville EA: Relationships between
drug activity in NCI preclinical in vitro and in vivo models and
early clinical trials. Br J Cancer. 84:1424–1431. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Ni Z, Nie X, Zhang H, Wang L, Geng Z, Du
X, Qian H, Liu W and Liu T: Atranorin driven by nano materials
SPION lead to ferroptosis of gastric cancer stem cells by weakening
the mRNA 5-hydroxymethylcytidine modification of the Xc-/GPX4 axis
and its expression. Int J Med Sci. 19:1680–1694. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Shanavas S, Sen U, Banerjee R, Shenoy PS
and Bose B: Effective targeting of colorectal cancer stem cells by
inducing differentiation mediated by low-dose vitamin C via
β-catenin retention in the cell membrane. J Cell Biochem.
126:e306862025. View Article : Google Scholar
|
|
147
|
Paganelli F, Chiarini F, Palmieri A,
Martinelli M, Sena P, Bertacchini J, Roncucci L, Cappellini A,
Martelli AM, Bonucci M, et al: The Combination of AHCC and ETAS
decreases migration of colorectal cancer cells, and reduces the
expression of LGR5 and Notch1 genes in cancer stem cells: A novel
potential approach for integrative medicine. Pharmaceuticals
(Basel). 14:13252021. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Mao Y, Shangguan D, Huang Q, Xiao L, Cao
D, Zhou H and Wang YK: Emerging artificial intelligence-driven
precision therapies in tumor drug resistance: Recent advances,
opportunities, and challenges. Mol Cancer. 24:1232025. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Zhang Z, Wang ZX, Chen YX, Wu HX, Yin L,
Zhao Q, Luo HY, Zeng ZL, Qiu MZ and Xu RH: Integrated analysis of
single-cell and bulk RNA sequencing data reveals a pan-cancer
stemness signature predicting immunotherapy response. Genome Med.
14:452022. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Xia X, Zhu C, Zhong F and Liu L: TransCDR:
A deep learning model for enhancing the generalizability of drug
activity prediction through transfer learning and multimodal data
fusion. BMC Biol. 22:2272024. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Zhao X, Singhal A, Park S, Kong J,
Bachelder R and Ideker T: Cancer mutations converge on a collection
of protein assemblies to predict resistance to replication stress.
Cancer Discov. 14:508–523. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Varinelli L, Illescas O, Lorenc EJ,
Battistessa D, Di Bella M, Zanutto S and Gariboldi M: Organoids
technology in cancer research: from basic applications to advanced
ex vivo models. Front Cell Dev Biol. 13:15693372025. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Beshiri ML, Tice CM, Tran C, Nguyen HM,
Sowalsky AG, Agarwal S, Jansson KH, Yang Q, McGowen KM, Yin J, et
al: A PDX/Organoid biobank of advanced prostate cancers captures
genomic and phenotypic heterogeneity for disease modeling and
therapeutic screening. Clin Cancer Res. 24:4332–4345. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Zhu Z, Shen J, Ho PC, Hu Y, Ma Z and Wang
L: Transforming cancer treatment: Integrating patient-derived
organoids and CRISPR screening for precision medicine. Front
Pharmacol. 16:15631982025. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Li P, Huang M, Li M, Li G, Ma Y, Zhao Y,
Wang X, Zhang Y and Shi C: Combining molecular characteristics and
therapeutic analysis of PDOs predict clinical responses and guide
PDAC personalized treatment. J Exp Clin Cancer Res. 44:722025.
View Article : Google Scholar : PubMed/NCBI
|
